{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:50Z","timestamp":1761513770452},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T00:00:00Z","timestamp":1455667200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry of Science Republic of Serbia Project","award":["175033"],"award-info":[{"award-number":["175033"]}]},{"name":"Genetic analysis of the PROP1 gene was performed in Laboratoire de Biologie Moleculaire,Hopital de la Conception,Marseille,France"},{"name":"Genetic testing of the BRCA1 and BRCA2 genes was performed in the North East Thames Regional Genetics Laboratory,Great Ormond Street Hospital for Children, London,UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1007\/s12020-016-0868-y","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T05:21:28Z","timestamp":1455686488000},"page":"231-235","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cancerous leptomeningitis and familial congenital hypopituitarism"],"prefix":"10.1007","volume":"52","author":[{"given":"S.","family":"Vujovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vujosevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kavaric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Sopta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ivovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Saveanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Brue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Popovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,17]]},"reference":[{"issue":"7","key":"868_CR1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc1387","volume":"4","author":"MN Pollak","year":"2004","unstructured":"M.N. Pollak, E.S. Schernhammer, S.E. Hankinson, Insulin-like growth factors and neoplasia. Nat. Rev. Cancer 4(7), 505\u2013518 (2004)","journal-title":"Nat. Rev. Cancer"},{"issue":"9418","key":"868_CR2","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0140-6736(04)16044-3","volume":"24;363","author":"AG Renehan","year":"2004","unstructured":"A.G. Renehan, M. Zwahlen, C. Minder, S.T. Odwyer, S. Shalet, M. Egger, Insulin-like growth factor (IGF)-I, IGF binding protein 3 and cancer risk: systematic review and meta-regression analysis. Lancet 24;363(9418), 1346\u20131353 (2004)","journal-title":"Lancet"},{"key":"868_CR3","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1210\/en.2005-0058","volume":"146","author":"WE Sonntag","year":"2005","unstructured":"W.E. Sonntag, C.S. Carter, Y. Ikeno, K. Ekenstedt, C.S. Carlson, R.F. Loeser, S. Chakrabarty, S. Lee, C. Bennett, R. Ingram, T. Moore, M. Ramsey, Adult-onset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology 146, 2920\u20132932 (2005)","journal-title":"Endocrinology"},{"issue":"4","key":"868_CR4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1530\/EJE-10-0859","volume":"164","author":"R Steuerman","year":"2011","unstructured":"R. Steuerman, O. Shevah, Z. Laron, Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies. Eur. J. Endocrinol. 164(4), 485\u2013489 (2011)","journal-title":"Eur. J. Endocrinol."},{"issue":"70","key":"868_CR5","doi-asserted-by":"crossref","first-page":"70ra13","DOI":"10.1126\/scitranslmed.3001845","volume":"3","author":"J Guevara-Aguirre","year":"2011","unstructured":"J. Guevara-Aguirre, P. Balasubramanian, M. Guevara-Aguirre, M. Wei, F. Madia, C.W. Cheng, D. Hwang, A. Martin-Montalvo, J. Saavedra, S. Ingles, C.R. De, P. Cohen, V.D. Longo, Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 3(70), 70ra13 (2011). doi: 10.1126\/scitranslmed.3001845","journal-title":"Sci. Transl. Med."},{"key":"868_CR6","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/384327a0","volume":"384","author":"MW Sornson","year":"1996","unstructured":"M.W. Sornson, W. Wu, J.S. Dasen, S.E. Flynn, D.J. Norman, S.M. O\u2019Connell, I. Gukovsky, C. Carrie`re, A.K. Ryan, A.P. Miller, L. Zuo, A.S. Gleiberman, B. Andersen, W.G. Beamer, M.G. Rosenfeld, Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327\u2013333 (1996)","journal-title":"Nature"},{"key":"868_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ng0298-147","volume":"18","author":"W Wu","year":"1998","unstructured":"W. Wu, J.P. Cogan, R.W. Pfaffle, J.S. Dasen, H. Frisch, S.M. OConnell, S.E. Flynn, M.R. Brown, P.E. Mullis, J.S. Parks, J.A. Phillips, M.G. Rosenfeld, Mutation in PROP1 cause familial combined pituitary hormone deficiency. Nat. Genet. 18, 147\u2013149 (1998)","journal-title":"Nat. Genet."},{"key":"868_CR8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1034\/j.1399-0004.2000.570503.x","volume":"57","author":"MT Dattani","year":"2000","unstructured":"M.T. Dattani, I.C. Robinson, The molecular basis for developmental disorders of the pituitary gland in man. Clin. Genet. 57, 337\u2013346 (2000)","journal-title":"Clin. Genet."},{"key":"868_CR9","first-page":"50","volume":"84","author":"AL Rosenbloom","year":"1999","unstructured":"A.L. Rosenbloom, A.S. Almonte, M.R. Brown, D.A. Fisher, L. Baumbach, J.S. Parks, Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J. Clin. Endocrinol. Metab. 84, 50\u201357 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"868_CR10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1053\/beem.2002.0218","volume":"16","author":"S Mody","year":"2002","unstructured":"S. Mody, M. Brown, J.S. Parks, The spectrum of hypopituitarism caused by PROP1 mutations. Best Pract. Res. Clin. Endocrinol. Metab. 16, 421\u2013431 (2002)","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"868_CR11","first-page":"32","volume":"1","author":"M Doknic","year":"2004","unstructured":"M. Doknic, S. Pekic, M. Djurovic, V. Zivkovic, V. Popovic, Multiple pituitary hormone deficiency (MPHD) associated with normal height, absent puberty and obesity. Pediatr. Endocrinol. Rev. 1, 32\u201333 (2004)","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"868_CR12","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1210\/jc.2009-1879","volume":"95","author":"MH Aguiar-Oliveira","year":"2010","unstructured":"M.H. Aguiar-Oliveira, F.T. Oliveira, R.M. Pereira, C.R. Oliveira, A. Blackford, E.H. Valenca, E.G. Santos, M.B. Gois-Junior, R.A. Meneguz-Moreno, V.P. Araujo, L.A. Oliveira-Neto, R.P. Almeida, M.A. Santos, N.T. Farias, D.C. Silveira, G.W. Cabral, F.R. Calazans, J.D. Seabra, T.F. Lopes, E.O. Rodrigues, L.A. Porto, I.P. Oliveira, E.V. Melo, M. Martari, R. Salvatori, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 95, 714\u2013721 (2010)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"868_CR13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.critrevonc.2013.01.005","volume":"87","author":"V Anisimov","year":"2013","unstructured":"V. Anisimov, A. Bartke, The key role of growth hormone-insulin-IGF1 signaling in aging and cancer. Crit. Rev. Oncol. Hematol. 87, 201\u2013223 (2013)","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"868_CR14","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1210\/jc.2011-2294","volume":"97","author":"RG Rosenfeld","year":"2012","unstructured":"R.G. Rosenfeld, P. Cohen, L.L. Robison, B.B. Bercu, P. Clayton, A.R. Hoffman, S. Radovick, P. Saenger, M.O. Savage, J.M. Wit, Long-term surveillance of growth hormone therapy. J. Clin. Endocrinol. Metab. 97, 68\u201372 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"868_CR15","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1530\/EJE-13-0389","volume":"169","author":"S Pekic","year":"2013","unstructured":"S. Pekic, V. Popovic, GH therapy and cancer risk in hypopituitarism: what we know from human studies. Eur. J. Endocrinol. 169(5), R89\u2013R97 (2013). doi: 10.1530\/EJE-13-0389","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"868_CR16","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"1:136","author":"J Ferlay","year":"2015","unstructured":"J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers, M. Rebelo, D.M. Parkin, D. Forman, F. Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int. J. Cancer Mar. 1:136(5), E359\u2013E386 (2015)","journal-title":"Int. J. Cancer Mar."},{"key":"868_CR17","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1007\/s12032-011-0076-9","volume":"29","author":"E Miller","year":"2012","unstructured":"E. Miller, I. Dy, T. Herzog, Leptomeningeal carcinomatosis from ovarian cancer. Med. Oncol. 29, 2010\u20132015 (2012)","journal-title":"Med. Oncol."},{"issue":"2","key":"868_CR18","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/modpathol.3800306","volume":"18","author":"DA Bell","year":"2005","unstructured":"D.A. Bell, Origins and molecular pathology of ovarian cancer. Mod. Pathol. 18(2), S19\u2013S32 (2005)","journal-title":"Mod. Pathol."},{"issue":"11","key":"868_CR19","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/hmg\/ddr087","volume":"20","author":"CL Pearce","year":"2011","unstructured":"C.L. Pearce, J. Doherty, D. Van Den Berg et al., Genetic variation in insulin-like growth factor 2 maz play a role in ovarian cancer risk. Hum. Mol. Genet. 20(11), 2263\u20132272 (2011)","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"868_CR20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/bjc.2014.566","volume":"112","author":"J Ose","year":"2014","unstructured":"J. Ose, R.T. Fortner, H. Schock et al., Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort. Br. J. Cancer 112(1), 162\u2013166 (2014). doi: 10.1038\/bjc.2014.566","journal-title":"Br. J. Cancer"},{"key":"868_CR21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3892\/mco.2015.516","volume":"3","author":"Q Wang","year":"2015","unstructured":"Q. Wang, C. Bian, H. Peng, X. Zhao, Association of circulating insulin-like growth factor 1 and insulin-like growth factor binding protein 3 with the risk of ovarian cancer: a systematic review and meta-analysis. Mol. Clin. Oncol. 3, 623\u2013628 (2015)","journal-title":"Mol. Clin. Oncol."},{"key":"868_CR22","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1038\/srep12891","volume":"5","author":"C Frank","year":"2015","unstructured":"C. Frank, M. Fallah, J. Sundquist, A. Hemminki, K. Hemminki, Population landscape of familial cancer. Sci. Rep. 5, 12891 (2015). doi: 10.1038\/srep12891","journal-title":"Sci. Rep."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0868-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-016-0868-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-016-0868-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T17:33:41Z","timestamp":1567618421000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-016-0868-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,17]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["868"],"URL":"https:\/\/doi.org\/10.1007\/s12020-016-0868-y","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,17]]}}}